Heppenheimer
Well-Known Member
I caught this on the BBC today:
Beyond the thrust of the article about the British government cancelling the contract with the manufacturer, of more broad interest is the Valneva vaccine itself. I don't know if any regulatory body has yet approved this particular vaccine, but if it ever makes it to the US, it can provide an alternative to those who claim they refuse the vaccine because the technologies behind Pfizer-BIONTECH, Moderna and Jansen's vaccines are "too new". Valneva takes advantage of the standard technique of using a "killed" pathogen, which has been successfully and safely deployed since the 1800s.
Without taking a deeper internet dive than I have the time for, I could not find any published data on this vaccine's efficacy, and it doesn't look like the company has any immediate plans to submit their product for FDA review. But it would be nice to have another option to counter the "it's too new" arguments, although that will almost certainly be followed by other new excuse on why they can't get even this vaccine.
UK scraps Covid-19 vaccine deal with French firm Valneva
The French firm says the deal was cancelled over allegations of a breach of the agreement, which it denies.
www.bbc.com
Beyond the thrust of the article about the British government cancelling the contract with the manufacturer, of more broad interest is the Valneva vaccine itself. I don't know if any regulatory body has yet approved this particular vaccine, but if it ever makes it to the US, it can provide an alternative to those who claim they refuse the vaccine because the technologies behind Pfizer-BIONTECH, Moderna and Jansen's vaccines are "too new". Valneva takes advantage of the standard technique of using a "killed" pathogen, which has been successfully and safely deployed since the 1800s.
Without taking a deeper internet dive than I have the time for, I could not find any published data on this vaccine's efficacy, and it doesn't look like the company has any immediate plans to submit their product for FDA review. But it would be nice to have another option to counter the "it's too new" arguments, although that will almost certainly be followed by other new excuse on why they can't get even this vaccine.